Application of nicardipine prolonged-release implants: Analysis of 97 consecutive patients with acute subarachnoid hemorrhage [1]

Neurosurgery

Volumn 58, Issue 4, 2006, Pages

  Hänggi, Daniel ^a   Steiger, Hans Jakob ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NICARDIPINE;

ACUTE DISEASE; BRAIN VASOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CLASSIFICATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG IMPLANT; DRUG POTENCY; HUMAN; INCIDENCE; LETTER; LOCAL THERAPY; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; SUSTAINED DRUG RELEASE;

ACUTE DISEASE; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; HUMANS; NICARDIPINE; SUBARACHNOID HEMORRHAGE;

EID: 33645794015     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980.
2. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T: Application of nicardipine prolonged-release implants: Analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 56:895-902, 2005.
3. Pradilla G, Wang PP, Legnani FG, Frazier JL, Tamargo RJ: Pharmacokinetics of controlled-release polymers in the subarachnoid space after subarachnoid hemorrhage in rabbits. J Neurosurg 101:99-103, 2004.
4. Suzuki J, Komatsu S, Sato T, Sakurai Y: Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid haemorrhage. Acta Neurochir (Wien) 55:63-70, 1980.